ArticleThe Journal of clinical investigation2026

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

Sarah R DiNapoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.